1. Home
  2. CMCO vs CINGW Comparison

CMCO vs CINGW Comparison

Compare CMCO & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMCO
  • CINGW
  • Stock Information
  • Founded
  • CMCO 1875
  • CINGW N/A
  • Country
  • CMCO United States
  • CINGW United States
  • Employees
  • CMCO N/A
  • CINGW 13
  • Industry
  • CMCO Construction/Ag Equipment/Trucks
  • CINGW Biotechnology: Pharmaceutical Preparations
  • Sector
  • CMCO Industrials
  • CINGW Health Care
  • Exchange
  • CMCO Nasdaq
  • CINGW Nasdaq
  • Market Cap
  • CMCO N/A
  • CINGW N/A
  • IPO Year
  • CMCO 1996
  • CINGW 2021
  • Fundamental
  • Price
  • CMCO $14.90
  • CINGW $0.05
  • Analyst Decision
  • CMCO Buy
  • CINGW
  • Analyst Count
  • CMCO 2
  • CINGW 0
  • Target Price
  • CMCO $44.00
  • CINGW N/A
  • AVG Volume (30 Days)
  • CMCO 509.7K
  • CINGW N/A
  • Earning Date
  • CMCO 05-28-2025
  • CINGW N/A
  • Dividend Yield
  • CMCO 1.89%
  • CINGW N/A
  • EPS Growth
  • CMCO N/A
  • CINGW N/A
  • EPS
  • CMCO N/A
  • CINGW N/A
  • Revenue
  • CMCO $963,027,000.00
  • CINGW N/A
  • Revenue This Year
  • CMCO N/A
  • CINGW N/A
  • Revenue Next Year
  • CMCO $16.80
  • CINGW N/A
  • P/E Ratio
  • CMCO N/A
  • CINGW N/A
  • Revenue Growth
  • CMCO N/A
  • CINGW N/A
  • 52 Week Low
  • CMCO $11.78
  • CINGW N/A
  • 52 Week High
  • CMCO $41.05
  • CINGW N/A
  • Technical
  • Relative Strength Index (RSI)
  • CMCO 43.42
  • CINGW N/A
  • Support Level
  • CMCO $13.66
  • CINGW N/A
  • Resistance Level
  • CMCO $19.17
  • CINGW N/A
  • Average True Range (ATR)
  • CMCO 0.99
  • CINGW 0.00
  • MACD
  • CMCO -0.35
  • CINGW 0.00
  • Stochastic Oscillator
  • CMCO 22.50
  • CINGW 0.00

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: